Home  >  Research  >  Labs  >  Cancer Program  >  LIVER DISEASE AND CARCINOGENESIS

RESEARCH OVERVIEW

Our research group focuses on the liver progenitor/stem cell (LPSC) which we identify in patients with alcoholic liver disease (ALD), hepatitis C (HCV), genetic hemochromatosis (GH) and non-alcoholic fatty liver disease (NAFLD). An objective of our research is to utilise their presence as a diagnostic to detect early stages of pathology and their abundance as an indicator of disease severity. Since ALD, GH, HCV and NAFLD increase the likelihood of developing hepatocellular carcinoma (HCC), the LPSCs may also be useful as a prognostic for patients who will develop liver cancer.

We are well-placed to undertake these studies as we have a monoclonal antibody that detects the LPSCs in liver biopsies. Our recent studies suggest that the protein this antibody binds to is present in the blood of patients who harbour LPSCs in their liver. This raises the possibility of developing a blood test that informs clinicians of the state of the patient’s liver.

The LPSC is present in diseased liver because it has an important role in repairing the damaged organ. It is a functional stem cell that can produce cholangiocytes that make up the bile ducts; or it can produce hepatocytes that are responsible for the major functions of the liver. To better study this important liver cell, we have established LPSC lines from both the mouse and human to understand what makes them grow and how they decide between generating cholangiocytes and hepatocytes.

This work has produced a valuable resource in the form of LPSC lines that are non-cancerous and others that are tumorigenic. This provides a platform for screening and testing for anti-liver cancer drugs that are selectively effective against liver cancer cells.

 

Emeritus Professor George Yeoh

Emeritus Professor George Yeoh

Liver Disease and Carcinogenesis

Read more

LATEST NEWS

The Perkins reaches major milestone in delivery of a Comprehensive Cancer Centre for WA

The Harry Perkins Institute of Medical Research (the Perkins) is pleased to advise that we have now reached a very significant milestone in progressing the development of the Perkins WA Comprehensive Cancer Centre for Western Australia. The Perkins has received a letter from the WA Health Minister, who on behalf…

Read More

Genetic tests to identify people at higher risk of heart failure

A groundbreaking study by researchers at Perth’s Harry Perkins Institute of Medical Research has produced a genetic test for heart failure, which will enable early intervention and more personalised treatment for heart disease patients. The research published last week in the International Journal of Molecular Science was led by Perkins…

Read More

New technology revealing genetics of recurrent pregnancy loss

Every day in Australia, 282 women experience a miscarriage, according to the The Pink Elephants Support Network. Chromosomal abnormalities are one of the more commonly recognised causes of recurrent miscarriage. Professor Gina Ravenscroft — Group Leader, Rare Disease Genetics & Functional Genomics Group at the Harry Perkins Institute of Medical…

Read More

I'M LOOKING FOR

RESEARCH PROJECTS

TEAM MEMBERS

PUBLICATIONS